These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28554744)

  • 1. Analysis of histological and immunohistochemical patterns of benign and malignant adrenocortical tumors by computerized morphometry.
    Dalino Ciaramella P; Vertemati M; Petrella D; Bonacina E; Grossrubatscher E; Duregon E; Volante M; Papotti M; Loli P
    Pathol Res Pract; 2017 Jul; 213(7):815-823. PubMed ID: 28554744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases.
    Duregon E; Fassina A; Volante M; Nesi G; Santi R; Gatti G; Cappellesso R; Dalino Ciaramella P; Ventura L; Gambacorta M; Dei Tos AP; Loli P; Mannelli M; Mantero F; Berruti A; Terzolo M; Papotti M
    Am J Surg Pathol; 2013 Sep; 37(9):1433-40. PubMed ID: 23774167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.
    Gan W; Han X; Gong Y; Yang Y; Wang C; Zhang Z
    Diagn Pathol; 2024 May; 19(1):71. PubMed ID: 38802933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.
    Yamazaki Y; Nakamura Y; Shibahara Y; Konosu-Fukaya S; Sato N; Kubota-Nakayama F; Oki Y; Baba S; Midorikawa S; Morimoto R; Satoh F; Sasano H
    Hum Pathol; 2016 Jul; 53():41-50. PubMed ID: 26980031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors.
    Pinheiro C; Granja S; Longatto-Filho A; Faria AM; Fragoso MC; Lovisolo SM; Lerário AM; Almeida MQ; Baltazar F; Zerbini MC
    Oncotarget; 2015 Dec; 6(42):44403-21. PubMed ID: 26587828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions.
    Blanes A; Diaz-Cano SJ
    Hum Pathol; 2006 Oct; 37(10):1295-303. PubMed ID: 16949934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
    Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
    Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal cortical neoplasms: a study of clinicopathological features related to epidermal growth factor receptor gene status.
    Zhang J; Wang C; Gao J; Sun J; Zeng X; Wu S; Liang Z
    Diagn Pathol; 2014 Jan; 9():19. PubMed ID: 24457059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma.
    Sasano H; Suzuki T; Moriya T
    Endocr Pathol; 2006; 17(4):345-54. PubMed ID: 17525483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
    Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
    Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.
    Duregon E; Cappellesso R; Maffeis V; Zaggia B; Ventura L; Berruti A; Terzolo M; Fassina A; Volante M; Papotti M
    Hum Pathol; 2017 Apr; 62():1-7. PubMed ID: 27916625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases.
    Duregon E; Volante M; Bollito E; Goia M; Buttigliero C; Zaggia B; Berruti A; Scagliotti GV; Papotti M
    Hum Pathol; 2015 Dec; 46(12):1799-807. PubMed ID: 26472162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallothionein protein and minichromosome maintenance protein-2 expression in adrenocortical tumors.
    Saiegh L; Sheikh-Ahmad M; Shechner C; Reut M; Darawsha Y; Zolotov S; Shefer H; Bejar I; Bejar J
    Ann Endocrinol (Paris); 2019 Nov; 80(5-6):324-328. PubMed ID: 31703800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myxoid Adrenocortical Adenoma: A report of two cases and literature review.
    Wu H; Zhang F; Chen Y; Liu C; Yao S; Zhu X; Luo X; Zhuang H; Liu Y
    Pathol Res Pract; 2017 Jul; 213(7):857-859. PubMed ID: 28559117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
    Romero Arenas MA; Whitsett TG; Aronova A; Henderson SA; LoBello J; Habra MA; Grubbs EG; Lee JE; Sircar K; Zarnegar R; Scognamiglio T; Fahey TJ; Perrier ND; Demeure MJ
    Ann Surg Oncol; 2018 Mar; 25(3):801-807. PubMed ID: 29218429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas.
    Ye J; Qi Y; Wang W; Sun F; Wei Q; Su T; Zhou W; Jiang Y; Yuan W; Cai J; Cui B; Ning G
    Endocrine; 2012 Jun; 41(3):479-86. PubMed ID: 22311173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and Prognostic Biomarkers of Adrenal Cortical Carcinoma.
    Mete O; Gucer H; Kefeli M; Asa SL
    Am J Surg Pathol; 2018 Feb; 42(2):201-213. PubMed ID: 28877067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic features and expression of epidermal growth factor receptor and vascular endothelial growth factor in adrenocortical tumors].
    Wang CP; Zhang J; Gao J; Liu PP; Wu SF; Zeng X; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):686-90. PubMed ID: 23302311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
    Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical tumors in Brazilian children: immunohistochemical markers and prognostic factors.
    Sbragia L; Oliveira-Filho AG; Vassallo J; Pinto GA; Guerra-Junior G; Bustorff-Silva J
    Arch Pathol Lab Med; 2005 Sep; 129(9):1127-31. PubMed ID: 16119984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.